Variable | Univariate | Multivariate | ||||
---|---|---|---|---|---|---|
HR | 95% CI | p-value | HR | 95% CI | p-value | |
Age (per 1 year) | 1.042 | 1.029–1.056 | < 0.001 | 1.023 | 1.008–1.038 | 0.002 |
Male | 0.663 | 0.486–0.904 | 0.009 | 0.944 | 0.666–1.354 | 0.774 |
Diabetes mellitus | 1.780 | 1.327–2.387 | < 0.001 | 1.384 | 1.004–1.907 | 0.047 |
Hipertension | 1.480 | 1.103–1.986 | 0.009 | 0.999 | 0.719–1.390 | 0.997 |
Stroke history | 2.602 | 1.617–4.189 | < 0.001 | 1.954 | 1.193–3.200 | 0.008 |
History of CAD | 1.370 | 1.013–1.852 | 0.011 | 1.113 | 0.804–1.542 | 0.518 |
Major bleeding | 1.898 | 0.970–3.713 | 0.068 | 0.812 | 0.395–1.669 | 0.571 |
Multi-vessel disease | 1.872 | 1.392–2.518 | < 0.001 | 1.197 | 0.866–1.654 | 0.276 |
Killip class ≥2 | 5.545 | 3.981–7.722 | < 0.001 | 4.149 | 2.907–5.922 | < 0.001 |
LVEF (per 1% change) | 0.957 | 0.945–0.969 | < 0.001 | 0.972 | 0.958–0.986 | < 0.001 |
Hemoglobin (per 1 mg/dl) | 0.805 | 0.748–0.866 | < 0.001 | 0.887 | 0.816–0.965 | 0.005 |
WBC (per 103/L) | 1.081 | 1.043–1.121 | < 0.001 | 1.063 | 1.024–1.103 | 0.001 |
B-blocker use at follow-up | 0.489 | 0.351–0.682 | < 0.001 | 0.638 | 0.444–0.917 | 0.015 |
ACE/ARB use at follow-up | 0.452 | 0.331–0.619 | < 0.001 | 0.989 | 0.668–1.464 | 0.956 |
TVR | 0.490 | 0.266–0.902 | 0.022 | 0.765 | 0.410–1.4128 | 0.401 |
MELDa score (per 1 point) | 1.291 | 1.222–1.364 | < 0.001 | 1.116 | 1.069–1.164 | < 0.001 |